Clinical Evaluation of Natural History of Peyronie’s Disease: Our Experience, Old Myths and New Certainties

E-ISSN： 2212-4055|12|5|341-348

ISSN： 1871-5281

Source： Inflammation & Allergy-Drug Targets (Formerly Current Drug Targets - Inflammation & Allergy), Vol.12, Iss.5, 2013-10, pp. : 341-348

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Peyronie’s disease: an update of the medical management

By Maan Zafar Arya Manit Shergill Iqbal Joseph Jean V Patel Hitendra RH

Expert Opinion on Pharmacotherapy, Vol. 5, Iss. 4, 2004-04 ,pp. : 799-805

Informa Healthcare

Access to resources Recommend Favorite

New study challenges old international pricing certainties

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 279, 2000-01 ,pp. : 3-4

Adis International

Access to resources Recommend Favorite

Targeting ERBB Receptors to Inhibit Metastasis: Old Hopes and New Certainties

Current Cancer Drug Targets, Vol. 9, Iss. 1, 2009-02 ,pp. : 1-18

Bentham Science Publishers

Access to resources Recommend Favorite

Metrifonate (Trichlorfon): a review of the pharmacology, pharmacokinetics and clinical experience with a new acetylcholinesterase inhibitor for Alzheimer’s disease

By Cummings J.L. Ringman J.M.

Expert Opinion on Investigational Drugs, Vol. 8, Iss. 4, 1999-04 ,pp. : 463-471

Informa Healthcare

Access to resources Recommend Favorite

Tiludronate. A new treatment for an old ailment: Paget’s disease of bone

By Morales-Piga A.

Expert Opinion on Pharmacotherapy, Vol. 1, Iss. 1, 1999-11 ,pp. : 157-170

Informa Healthcare

Access to resources Recommend Favorite